Primucell FIP
Primucell FIP
Authorised
- Feline coronavirus, strain DF2-ts, Live
Product identification
Medicine name:
Primucell FIP
Active substance:
- Feline coronavirus, strain DF2-ts, Live
Target species:
-
Cat
Route of administration:
-
Nasal use
Product details
Active substance and strength:
-
Feline coronavirus, strain DF2-ts, Live25118900.00/tissue culture infective dose 501.00Dose
Pharmaceutical form:
-
Lyophilisate and solvent for oral suspension
Withdrawal period by route of administration:
-
Nasal use
- Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI06AA06
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Germany
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
- Zoetis Deutschland GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Zoetis Belgium
Responsible authority:
- PEI
Authorisation number:
- 426a/91
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 19/04/2022
How useful was this page?:
